Word

T

Status

Pending

Status Code

730

Status Date

Friday, March 22, 2024

Serial Number

97445032

Mark Type

3000

Filing Date

Monday, June 6, 2022

Published for Opposition

Tuesday, August 1, 2023

Trademark Owner History

Adaptive Biotechnologies Corp. - Owner At Publication

Classifications

5 Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use, namely, to detect cancer, autoimmune disease and infection; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use , namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection

44 Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical diagnostic and prognostic testing services; providing medical immunosequencing-based diagnostic and prognostic testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services relating to the diagnosis and treatment of persons

42 Providing information about medical research in the field medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples

The mark consists of the design of 3 stylized ovals with one on top and two horizontally below with the space between them forming a stylized letter "T".
Color is not claimed as a feature of the mark.

Trademark Events

Mar 23, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 22, 2024

Sou Extension 1 Granted

Mar 22, 2024

Sou Extension 1 Filed

Mar 22, 2024

Sou Teas Extension Received

Sep 26, 2023

Noa E-Mailed - Sou Required From Applicant

Aug 1, 2023

Official Gazette Publication Confirmation E-Mailed

Aug 1, 2023

Published For Opposition

Jul 12, 2023

Notification Of Notice Of Publication E-Mailed

Jun 27, 2023

Approved For Pub - Principal Register

Jun 23, 2023

Teas/Email Correspondence Entered

Jun 22, 2023

Correspondence Received In Law Office

Jun 22, 2023

Teas Response To Office Action Received

Mar 22, 2023

Notification Of Non-Final Action E-Mailed

Mar 22, 2023

Non-Final Action E-Mailed

Mar 22, 2023

Non-Final Action Written

Mar 20, 2023

Assigned To Examiner

Jun 16, 2022

Notice Of Design Search Code E-Mailed

Jun 15, 2022

New Application Office Supplied Data Entered

Jun 9, 2022

New Application Entered